PCYC-1128-CA: A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal And Genitourinary Tumors

December 01, 2015
https://clinicaltrials.gov/ct2/show/NCT02599324
Cancer - Gastro, Cancer - Genitourinary/ Prostate/ Kidney, Cancer - Genitourinary/ Bladder/ Prostate/ Urothel
Principal Investigator: Ding Wang, MD

Advanced cancer, gastrointestinal cancer, kidney cancer, bladder cancer, stomach cancer, genitourinary cancer

Accepting Participants